Galderma Group AG

Common Name
Galderma Group
Country
Switzerland
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
6,545
Ticker
GALD
Exchange
SIX SWISS EXCHANGE
Description
Galderma Group AG is a leading global pure-play dermatology company dedicated exclusively to skin health. Founded in 1981 and headquartered in Zug, Switzerland, the company offers a science-driven por...

Financial Statements of Galderma Group

Below are the financial statements of Galderma Group, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of USD20242023
Non-current assets
Goodwill
5,129a
5,129a
Intangible assets
4,829a
4,923a
Property, plant and equipment
577a
529a
Deferred tax assets
211a
235a
Employee benefits assets
0a
0a
Derivative assets
2a
9a
Other financial assets
1a
10a
Other assets
25a
20a
Total non-current assets
10,774a
10,855a
Current assets
Inventories
403a
420a
Trade and other receivables
892a
750a
Prepayments and accrued income
56a
56a
Current income tax assets
13a
15a
Derivative assets
22a
7a
Cash and cash equivalents
457a
368a
Total current assets
1,843a
1,616a
Total assets
12,617a
12,471a
Non-current liabilities
Financial debt
-2,723a
-4,846a
Other financial liabilities
-2a
-10a
Deferred tax liabilities
-420a
-431a
Derivative liabilities
-20a
-7a
Employee benefits
-117a
-221a
Provisions
-17a
-16a
Total non-current liabilities
-3,299a
-5,531a
Current liabilities
Financial debt
-36a
-63a
Other financial liabilities
0a
-58a
Current income tax liabilities
-61a
-78a
Provisions
-38a
-60a
Accruals and deferred income
-586a
-527a
Trade and other payables
-676a
-653a
Employee benefits
-119a
-127a
Derivative liabilities
-10a
-5a
Total current liabilities
-1,528a
-1,571a
Total liabilities
-4,827a
-7,102a
Equity
Share capital and share premium
-2,136a
-6,259a
Other reserves
-48a
-43a
Hedge and currency translation reserves
55a
32a
Treasury share reserve
15a
0a
Retained earnings / accumulated losses
-5,676a
901a
Total equity
-7,790a
-5,369a
Total liabilities and equity
-12,617a
-12,471a
Download Data

Verified Sources Behind Galderma Group’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Galderma Group’s data sources below and access millions more through our Disclosure Search.

a. Galderma Group's Financial Report 2024
a. Galderma Group's Financial Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?